America’s Underinsurance Crisis in the Age of COVID-19
The COVID-19 pandemic has shone a light on the underinsurance crisis that has long kept millions of Americans on the precipice of financial disaster.

This post reflects on the ethical implications of FDA’s use of its emergency powers, and suggests opportunities for greater accountability moving forward.

A Biologics License Application, or BLA, is FDA’s standard “full approval” mechanism for biological products, including therapeutics and vaccines.

There are a series of practical reforms that could readily improve the quality of nursing home care.

Highlights from a discussion of the ethical and legal implications of COVID-19 digital health passes, often called vaccine passports.
